2025 Annual Meeting | PL1 - Controversies in Neurology Plenary Session

Saturday 04/05/25
09:15 AM - 11:15 AM PDT Add To Calendar
San Diego Convention Center | Ballroom 20
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Plenary Session
Rashmi B. Halker Singh, MD, FAAN, Roneil Malkani, MD
General Neurology
2.00 CME credits

Program Materials

Event Timeline
09:15 AM - 09:55 AM PDT Speaker Biomarker-based Diagnosis of Parkinson’s Disease: Are We Ready to Adopt a Biological Definition in Research?
Paolo Calabresi, MD, Kathleen Poston, MD, FAAN
09:55 AM - 10:35 AM PDT Speaker Blood Pressure Targets in ICH: Should We Go Low?
Chitra Venkatasubramanian, MD, MBBS, MSc, Kara R. Melmed, MD
10:35 AM - 11:15 AM PDT Speaker Should CGRP Antagonists Be First Line for Migraine Treatment?
Andrew Charles, MD, Elizabeth Loder, MD, FACP
Faculty Disclosures
Rashmi B. Halker Singh, MD, FAAN Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Halker Singh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology & Neuroscience Reports. Dr. Halker Singh has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Headache Journal. Dr. Halker Singh has received publishing royalties from a publication relating to health care. Dr. Halker Singh has received personal compensation in the range of $5,000-$9,999 for serving as a CME speaker with Pri-med. Dr. Halker Singh has received personal compensation in the range of $500-$4,999 for serving as a CME speaker with Medscape.
Roneil Malkani, MD The institution of Dr. Malkani has received research support from NIH. The institution of Dr. Malkani has received research support from Northwestern University. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Author with 好色先生. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with Weston Family Foundation. Dr. Malkani has received personal compensation in the range of $500-$4,999 for serving as a Consultant with American Academy of Sleep Medicine. Dr. Malkani has a non-compensated relationship as a Committee Member with American Academy of Sleep Medicine that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Board Member with Illinois Sleep Society that is relevant to AAN interests or activities. Dr. Malkani has a non-compensated relationship as a Review editor on editorial board with Frontiers that is relevant to AAN interests or activities.
Chitra Venkatasubramanian, MD, MBBS, MSc Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell . Dr. Venkatasubramanian has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McKeen and associates. Dr. Venkatasubramanian has stock in Ceribell. The institution of Dr. Venkatasubramanian has received research support from Bard Inc. The institution of Dr. Venkatasubramanian has received research support from Biogen. The institution of Dr. Venkatasubramanian has received research support from NIH.
Kara R. Melmed, MD Dr. Melmed has nothing to disclose.
Andrew Charles, MD Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vectura. The institution of Dr. Charles has received research support from NIH. Dr. Charles has received publishing royalties from a publication relating to health care. Dr. Charles has a non-compensated relationship as a Executive Board Member with American Headache Society that is relevant to AAN interests or activities.
Elizabeth Loder, MD, FACP Dr. Loder has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Loder has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The BMJ.
Kathleen Poston, MD, FAAN Dr. Poston has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Curasen Therapeutics, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Amprion, INC. Dr. Poston has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. Dr. Poston has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. Dr. Poston has stock in Curasen Therapeutics, INC. Dr. Poston has stock in Amprion, INC. The institution of Dr. Poston has received research support from NIH. The institution of Dr. Poston has received research support from Michael J Fox Foundation. The institution of Dr. Poston has received research support from Alzheimer's Drug Discovery Foundation . The institution of Dr. Poston has received research support from Lewy Body Dementia Association. Dr. Poston has received intellectual property interests from a discovery or technology relating to health care.
Paolo Calabresi, MD Dr. Calabresi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie, Bial, Bayer Schering, Biogen-Dompè, Biogen-Idec, Eisai, Lilly, Lundbeck, Lusofarmaco, Merck-Serono, Novartis, Sanofi-Genzyme, Teva, UCB Pharma, Zambon..